X hits on this document





8 / 9

Cancer Therapy: Clinical

  • 18.

    Luthra R, Sanchez-Vega B, Medeiros LJ. Quantita- tiveTaqMan t(9;22)(q34;q11) PCR coupled with cap- illary electrophoresis-based identification of bcr-abl fusion sequences. Mod Pathol 2004;17:96 ^ 103.

  • 19.

    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 157 ^ 160.

  • 20.

    Peto R, Peto J. Asymptotically efficient rank invariant procedures. JR Stat Soc [SerA] 1972;135:185^ 207.

  • 21.

    Agresti A. Categorical data analysis. 7th ed. New York: JohnWiley & Sons; 1972.

  • 22.

    Branford S, Rudzki Z, Grigg A, et al. BCR-ABL levels continue to decrease up to 42 months after com-

mencement of standard dose imatinib in patients with newly diagnosed chronic phase CML who achieve a major molecular response [abstract #274]. Blood 2004;104:82a.

  • 23.

    Rosti G, Martinelli G, Bassi S, et al. Molecular re- sponse to imatinib in late chronic-phase chronic mye- loid leukemia. Blood 2004;103:2284 ^ 90.

  • 24.

    Merx K, Muller MC, Kreil S, et al. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon a. Leukemia 2002; 16:1579 ^ 83.

  • 25.

    Wang L, Pearson K, FergusonJE, Clark RE.The early

molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia. Br JHaematol 2003;120:990 ^ 9.

  • 26.

    Muller MC, Gattermann N, Lahaye T, et al. Dynam- ics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon a/ara-C. Leukemia 2003;17: 2392 ^ 400.

  • 27.

    Branford S, Rudzki Z, Harper A, et al. Imatinib produces significantly superior molecular responses compared to interferon a plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Leukemia 2003;17:2401^ 9.

Clin Cancer Res 2005;11(9) May 1, 2005



Downloaded from clincancerres.aacrjournals.org on February 5, 2015. © 2005 American Association for Cancer Research.

Document info
Document views12
Page views12
Page last viewedFri Oct 21 13:16:23 UTC 2016